CPHA Canvax

"From the beginning of the COVID-19 pandemic there has been the belief that the only way we can return to “normal” life is with the development and distribution of safe and effective vaccines. In late 2020, two vaccines developed by Pfizer-BioNTech and Moderna were approved in Canada, the United States, and Europe, to protect adults from getting sick and possibly dying from COVID-19. News of these vaccines being developed and approved in less than one year has been met with excitement, hope, and but also skepticism, particularly among older adults and some of the most vulnerable members of our society." - COVID-19 Vaccines – What Older Canadians Need to Know

Rating See Comments Ratings


Program Planning and Delivery,Promotion and Communication,Communication,Specific Populations,Seniors,Monitoring and Surveillance,Outbreaks and Pandemics,COVID-19 Program Planning and Delivery
Promotion and Communication
Specific Populations
Monitoring and Surveillance
Outbreaks and Pandemics


Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.

All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.